More tax exemptions and incentives set for innovative pharmaceutical firms

With the domestic industry promotion law passed Friday, Korea will seek to expand tax exemptions for innovative pharmaceutical companies as part of efforts to stimulate state-run and private companies’ research and development (R&D) spending in the era of free trade agreements (FTAs).

In particular, the government decided to change the paradigm of industrial policies from a “Fast Follower’’ ...